Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.60
+0.01000.28%
Volume:112.38K
Turnover:399.40K
Market Cap:198.47M
PE:-3.18
High:3.63
Open:3.52
Low:3.46
Close:3.59
Loading ...

Voyager Therapeutics Q4 Basic EPS USD -0.59

THOMSON REUTERS
·
12 Mar

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

GlobeNewswire
·
12 Mar

Voyager Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
08 Mar

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), Senseonics Holdings (SENS) and Voyager Therapeutics (VYGR)

TIPRANKS
·
07 Mar

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

GlobeNewswire
·
04 Mar

Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment

MT Newswires Live
·
04 Mar

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Voyager Therapeutics Inc - Vy7523 Demonstrates Safety, Tolerability, and Dose-Proportional Pharmacokinetics in Sad Trial

THOMSON REUTERS
·
03 Mar

Voyager Therapeutics Inc - Initiates Multiple Ascending Dose Trial of Vy7523 in Early Alzheimer's Patients

THOMSON REUTERS
·
03 Mar

Voyager Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
01 Mar

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

GlobeNewswire
·
25 Feb

Voyager Therapeutics Executives Cash In: Major Stock Sales Revealed!

TIPRANKS
·
25 Feb

Voyager Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
25 Feb

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Q32 Bio (QTTB) and Vaxcyte (PCVX)

TIPRANKS
·
13 Feb

Voyager Therapeutics Executives Cash In: A Look at Recent Stock Sales

TIPRANKS
·
13 Feb

Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now

Insider Monkey
·
12 Feb

Voyager Therapeutics price target lowered to $12 from $14 at Wells Fargo

TIPRANKS
·
12 Feb

Wedbush Adjusts Price Target on Voyager Therapeutics to $9 From $11, Maintains Outperform Rating

MT Newswires Live
·
12 Feb

Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025

MT Newswires Live
·
11 Feb

Voyager Therapeutics to Assess 'Alternative Payloads' for ALS Gene Therapy Program

Dow Jones
·
11 Feb